These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32986750)

  • 1. Modelling bioactivities of combinations of whole extracts of edibles with a simplified theoretical framework reveals the statistical role of molecular diversity and system complexity in their mode of action and their nearly certain safety.
    Mayer P
    PLoS One; 2020; 15(9):e0239841. PubMed ID: 32986750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
    Ravikumar B; Aittokallio T
    Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
    Zhang W; Bai Y; Wang Y; Xiao W
    Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome inference and systems approaches to polypharmacology and drug discovery in herbal medicine.
    Li P; Chen J; Zhang W; Fu B; Wang W
    J Ethnopharmacol; 2017 Jan; 195():127-136. PubMed ID: 27894972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling Polypharmacological Profiles by Affinity Fingerprinting.
    Peragovics A; Simon Z; Malnasi-Csizmadia A; Bender A
    Curr Pharm Des; 2016; 22(46):6885-6894. PubMed ID: 27587199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.
    Chopra G; Samudrala R
    Curr Pharm Des; 2016; 22(21):3109-23. PubMed ID: 27013226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-nutritional Factors.
    Prog Drug Res; 2016; 71():43-7. PubMed ID: 26939264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacology: drug discovery for the future.
    Reddy AS; Zhang S
    Expert Rev Clin Pharmacol; 2013 Jan; 6(1):41-7. PubMed ID: 23272792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors.
    Reyes-Parada M; Iturriaga-Vasquez P
    Expert Opin Drug Discov; 2016 Oct; 11(10):969-81. PubMed ID: 27552487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice.
    Liu H; Wang J; Zhou W; Wang Y; Yang L
    J Ethnopharmacol; 2013 Apr; 146(3):773-93. PubMed ID: 23415946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth.
    Al-Ali H; Lee DH; Danzi MC; Nassif H; Gautam P; Wennerberg K; Zuercher B; Drewry DH; Lee JK; Lemmon VP; Bixby JL
    ACS Chem Biol; 2015 Aug; 10(8):1939-51. PubMed ID: 26056718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery.
    Lauria A; Bonsignore R; Bartolotta R; Perricone U; Martorana A; Gentile C
    Curr Pharm Des; 2016; 22(21):3073-81. PubMed ID: 26907944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mappability of drug-like space: towards a polypharmacologically competent map of drug-relevant compounds.
    Sidorov P; Gaspar H; Marcou G; Varnek A; Horvath D
    J Comput Aided Mol Des; 2015 Dec; 29(12):1087-108. PubMed ID: 26564142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MuSyC is a consensus framework that unifies multi-drug synergy metrics for combinatorial drug discovery.
    Wooten DJ; Meyer CT; Lubbock ALR; Quaranta V; Lopez CF
    Nat Commun; 2021 Jul; 12(1):4607. PubMed ID: 34326325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology.
    Lim H; He D; Qiu Y; Krawczuk P; Sun X; Xie L
    PLoS Comput Biol; 2019 Jun; 15(6):e1006619. PubMed ID: 31206508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting targeted polypharmacology for drug repositioning and multi- target drug discovery.
    Liu X; Zhu F; Ma XH; Shi Z; Yang SY; Wei YQ; Chen YZ
    Curr Med Chem; 2013; 20(13):1646-61. PubMed ID: 23410165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug2ways: Reasoning over causal paths in biological networks for drug discovery.
    Rivas-Barragan D; Mubeen S; Guim Bernat F; Hofmann-Apitius M; Domingo-Fernández D
    PLoS Comput Biol; 2020 Dec; 16(12):e1008464. PubMed ID: 33264280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polypharmacology of natural products.
    Ho TT; Tran QT; Chai CL
    Future Med Chem; 2018 Jun; 10(11):1361-1368. PubMed ID: 29673257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database.
    Barneh F; Jafari M; Mirzaie M
    Brief Bioinform; 2016 Nov; 17(6):1070-1080. PubMed ID: 26490381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.